Bruce Neal

Author of 5 Presentation(s)

02. Acute and Stable Ischemic Heart Disease: Clinical 1422-145

1422-145 - EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL

Session
1422 - Acute and Stable Ischemic Heart Disease: Clinical 7
Speakers
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1422-145
Presentation Rating
 4
02. Acute and Stable Ischemic Heart Disease: Clinical 1422-162

1422-162 - EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION

Session
1422 - Acute and Stable Ischemic Heart Disease: Clinical 7
Speakers
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1422-162
Presentation Rating
 Not Rated

Author of 3 Presentation(s)

02. Acute and Stable Ischemic Heart Disease: Clinical 1422-145

1422-145 - EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL

Session
1422 - Acute and Stable Ischemic Heart Disease: Clinical 7
Speakers
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1422-145
Presentation Rating
 4
02. Acute and Stable Ischemic Heart Disease: Clinical 1422-162

1422-162 - EFFECTS OF SGLT2 INHIBITORS ON STROKE IN TYPE 2 DIABETES ACCORDING TO BASELINE KIDNEY FUNCTION

Session
1422 - Acute and Stable Ischemic Heart Disease: Clinical 7
Speakers
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1422-162
Presentation Rating
 Not Rated